Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/9581
Title: HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso
Authors: Compaore, Tegwinde Rebeca
Diarra, Birama
Assih, Maleki
Obiri-Yeboah, Dorcas
Soubeiga, Serge Theophile
Ouattara, Abdoul Karim
Tchelougou, Damehan
Bisseye, Cyrille
Bakouan, Didier Romuald
Compaore, Issaka Pierre
Dembele, Augustine
Djigma, Wendkuuni Florencia
Simpore, Jacques
Keywords: HIV-1/HBV co-infection
APOBEC3G variants
Real time PCR
Burkina Faso
Issue Date: 2016
Publisher: BMC Infectious Diseases
Abstract: Background: Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G (APOBEC3G) is a potent host defense factor, which interferes with HIV-1 and HBV. Our study had three objectives, to screen a population of HIV-1 infected and uninfected patients in Burkina Faso for HBV, to screen the population for APOBEC3G variants rs6001417, rs8177832, and rs35228531 previously described, and to analyze the effect of these three variants and their haplotypes on HIV-1/HBV co-infection in Burkina Faso. Methods: HBV detection was performed on samples from HIV-1 infected and uninfected subjects using rapid detection tests and real-time PCR. APOBEC3 genotyping was done by the TaqMan allelic discrimination method. Fisher Exact test, Odds ratio (OR), confidence intervals (CI) at 95 %, Linkage disequilibrium (LD) summary statistics and haplotype frequencies were calculated. Results: The prevalence of HBV was 56.7 % among HIV-1 positive patients of our study while it was about 12.8 % among HIV-1 seronegative subjects. Genotype E was the genotype of HBV present in our hepatitis B positive samples. Minor allele frequencies of rs6001417, rs8177832, and rs35228531 were higher in seronegative subjects. The T minor allele of variant rs35228531 was protective against HIV-1/HBV co-infection with OR = 0.61, 95 % CI (0.42–0.90), p = 0.013. There was also an association between the GGT haplotype and protection against HIV-1/HBV co-infection, OR = 0.57, 95 % CI (0.33–0.99), p = 0.050. The other haplotypes present in the population were not statistically significant. There minor allele T of the rs35228531 was protective against HIV mono-infection OR = 0.53, 95 % CI (0.3–0.93), P = 0.030. But there was no effect of protection against HBV mono-infection. Conclusion: APOBEC3G through its variants rs6001417, rs8177832, and rs35228531, in this study interferes with HIV-1/HBV co-infection could be due the HIV-1 mono-infection in a population from Burkina Faso.
URI: http://hdl.handle.net/123456789/9581
Appears in Collections:School of Medical Sciences

Files in This Item:
File Description SizeFormat 
co-infection and APOBEC3G.pdfMAIN ARTICLE445.37 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.